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ABSTRACT   
The atypical two-component system (TCS) AbrC1/2/3 (encoded respectively by 
SCO4598/4597/4596), comprising two histidine kinases (HKs) and a response regulator 
(RR), is crucial for antibiotic production in Streptomyces coelicolor and for 
morphological differentiation under certain nutritional conditions. In this study we 
demonstrate that deletion of the RR-encoding gene abrC3, SCO4596, results in a 
dramatic decrease in ACT and RED production and delays morphological development. 
In contrast, the over-expression of abrC3 in the parent strain leads to a 33% increase in 
ACT production in liquid medium. Transcriptomic and ChIP-chip analyses of ∆abrC3 
and the parent strain revealed that AbrC3 directly controls ACT production by binding 
to the actII-ORF4 promoter region; this was independently verified by in vitro DNA-
binding assays. This binding is dependent on the sequence (5’-GAASGSGRMS-3’). In 
contrast, the regulation of RED production is not due to direct binding of AbrC3, either 
to the redZ or to the redD promoters regions. This study also revealed other members of 
the AbrC3 regulon: AbrC3 is a positive autoregulator, which also binds to the promoter 
regions of SCO0736, bdtA (SCO3328), absR1 (SCO6992), and SCO6809. The direct 
targets share the ten-base consensus binding sequence and may be responsible for some 
of the phenotypes of the ∆abrC3 mutant. The identification of the AbrC3 regulon as 
part of the complex regulatory network governing antibiotic production widens our 
knowledge regarding TCS involvement in control of antibiotic synthesis and may 
contribute to the rational design of new hyper-producer host strains through genetic 
manipulation of such systems. 
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INTRODUCTION  
Antibiotic production in Streptomyces is a complex process controlled by multiple 
factors through intricate genetic networks (1-4). This organism inhabits the soil where 
the environmental conditions are extremely variable and it must therefore compete with 
other organisms for scarce nutrients. Secretion of antibiotics provides a selective 
advantage to survive in this adverse environment (5) where it is important to respond 
quickly to different stimuli. 
TCSs are perhaps the most important signal transduction mechanism in bacteria (Mist-
web: http://mistdb.com/; P2CS-web: 
http://www.p2cs.org/index.php?PHPSESSID=4c2f13770410fa0fab046d10e6cf90d1) (6, 
7). Their relative abundance in a genome reflects an organism’s ability to adapt to 
different conditions, being less abundant for example in pathogens such as Chlamydia 
and Rickettsia than in free-living organisms such as Streptomyces or Myxococcus where 
more than 60 TCSs are present in their respective genomes (8-10). The only bacterial 
species lacking TCSs are intracellular pathogens (e.g. Mycoplasma species) and 
endosymbionts (e.g. Amoebophilus species) with severely reduced genomes (11). 
The Streptomyces AbrC1/2/3 gene cluster (SCO4598/97/96) constitutes an atypical TCS 
in that it consists of two histidine kinases (AbrC1 and AbrC2 HKs) of group II and one 
response regulator (AbrC3 RR) belonging to NarL group of the HTH LuxR family 
regulators (12). It is conserved across all Streptomyces species sequenced to date and is 
found to be critical for antibiotic production and morphological differentiation under 
certain culture conditions in S. coelicolor (13). Both kinases of the system (AbrC1 and 
AbrC2) share high similarity in their kinase domains (85%) although AbrC1 lacks an 
internal domain of 50 amino acid residues of AbrC2. Independent promoters control 
these three genes, even though the genes for HKs and cognate RRs of TCSs are usually 
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arranged in operons (14); these features are conserved in all sequenced Streptomyces 
species, suggesting the importance for regulation of these genes. The RR, AbrC3, has 
orthologues in more than 20 Streptomyces species sequenced, sharing more than 90% 
amino acid identity among them. The deletion of these three genes correlates with 
delayed morphological differentiation and a marked reduction in the production of the 
antibiotics in S. coelicolor M145: actinorhodin (ACT), undecylprodiginine (RED) and 
the calcium-dependent antibiotic (CDA) (13).  
In this work we present a detailed genetic, physiological and biochemical 
characterization of this important regulatory system. We show that deletion of abrC3 
alone leads to a dramatic reduction in ACT and RED production and morphological 
development in S. coelicolor. Moreover, overexpression of the AbrC3 regulator yields 
to high ACT production both in S. coelicolor and S. lividans. To better characterize the 
pleiotropic effects exhibited by ∆abrC3, we conducted a global transcriptome analysis 
comparing the ∆abrC3 and the parental strain and show that the low production of ACT 
observed in the abrC3 mutant is due to a general down-regulation of transcription of the 
act gene cluster. Other regulatory genes previously associated with antibiotic 
production, such as sihf (SCO1480) (15, 16), afsS (SCO4425) (17, 18) and absR1 
(SCO6992) (19), and with morphological development, for example, wblE (SCO5240) 
(20, 21) and bdtA (SCO3328) (22, 23) are also down-regulated in this mutant. 
Furthermore, through ChIP-chip analyses, we demonstrate a direct regulation of act 
gene expression through AbrC3 and provide independent verification with in vitro 
DNA-binding studies. This genome-wide study also revealed additional direct DNA 
targets of AbrC3. All of these targets share a common 10 bp sequence (5’-
GAASGSGRMS-3’) (S: G or C; R: A or G; M: A or C) and we have shown, by 
mutagenesis, that it is indispensable for the binding of AbrC3 to the actII-ORF4 
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promoter region. Therefore this sequence defines the putative consensus AbrC3 binding 
site. 
 
MATERIALS AND METHODS 
Strains, media and culture conditions 
Escherichia coli strain BW25113(pIJ790) (containing the λRed system) is an E. coli 
K12 (ΔaraBAD, ΔrhaBAD) derivative (24) and non-methylating ET12567(pUZ8002) is 
a dam, dcm, hsdS, cat, tet strain harbouring the tra genes in the non-transmissible RP4-
derivative plasmid, pUZ8002 (25). Both strains were grown in Luria–Bertani (LB) 
liquid broth or on LB agar (26). For CDA bioassays a parent strain of Bacillus subtilis 
(CECT 4522) was grown as an overlay on NA medium (27). S. lividans 66, S. 
coelicolor M145 (prototroph, SCP1-, SCP2-) and mutant strains were grown on R2YE 
and MS solid media for transformation and sporulation respectively (28). The liquid 
cultures used for transcriptional profiling and ChIP-chip were grown in NB medium at 
30 ºC in 500 ml baffled flasks with 160 ml of medium each in a shaking orbital 
incubator (250 rpm). When necessary the media was supplemented with antibiotics (E. 
coli media: 100 µg ml-1 for ampicillin, 50 µg ml-1 for apramycin, 50 µg ml-1 for 
kanamycin, 34 µg ml-1 for chloramphenicol, and 25 µg ml-1 for nalidixic acid. S. 
coelicolor media: 20 µg ml-1 for neomycin, 50 µg ml-1 for apramycin, and 20 µg ml-1 for 
hygromycin). 
Nucleic acid manipulations 
Plasmid isolation, restriction enzyme digestion, ligation, and transformation of E. coli 
and S. coelicolor were carried out as described in Sambrook et al (26) and Kieser et al 
 6 
(28), respectively. The plasmids and cosmids used are listed in Table S1. Total genomic 
DNA from S. coelicolor (gDNA) was isolated from a 24-36 h cultures in TSB medium 
following the procedure described in Hopwood et al (27), but scaled to 1-2 g of 
mycelium. 
When needed the DNA was sequenced on both strands using a Perkin Elmer ABI Prism 
377 DNA sequencer. In silico plasmid designs were obtained with the Gene 
Construction Kit software (GCK, Texco). 
Plasmid constructions 
Integrative plasmid pSETabrC3 was constructed by cloning the abrC3 gene under the 
regulation of its own promoter into the shuttle Streptomyces integrative plasmid 
pSET152.Tio using NdeI and BamHI restriction sites. This plasmid was used for 
complementation of the ∆abrC3 mutant strain (Table S1). 
The low copy number pHJLAbrC3 plasmid derived from pHJL401 (29) was obtained 
by cloning the abrC3 gene with its own promoter into pHJL401 using BamHI/EcoRI 
sites. 
The new plasmids were introduced into the corresponding Streptomyces strains by 
protoplast transformation as previously described (28). 
E. coli expression vector pETabrC3 was a derivative of pET22(b) plasmid, obtained by 
cloning the coding sequence for AbrC3 previously amplified by PCR with the 
corresponding oligonucleotides SRG-001 and SRG-002 (Table S2) in the NdeI/XhoI 
sites of the polylinker. 
AbrC3 over-expression in E. coli 
Cultures of E.coli BL21(DE3) transformed with pETabrC3 were induced with 1 mM 
IPTG to overproduce the AbrC3x6-His, subsequently purified with Ni-NTA (Qiagen) as 
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described before (30) and used to immunise two rabbits in order to obtain anti-AbrC3 
antibodies. 
Mutant construction (abrC3 knockout) 
The PCR-targeted system established by Gust et al. (31), was used to replace the 
complete coding sequence of abrC3 (SCO4596) located in cosmid SCD20 
(http://streptomyces.org.uk/) by the apramycin resistant gene aac(3)IV. The primers 
used to amplify the mutagenic cassette with pIJ773 as a template are listed in Table S2. 
The mutated cosmid SCD20∆abrC3::acc(3)IV obtained in E. coli BW25113(pIJ790) 
was demethylated in E. coli ET12567(pUZ8002) and transferred by conjugation to S. 
coelicolor M145. The desired double recombinants carrying apramycin resistance, 
while being sensitive to kanamycin (the selection marker for the vector sequences), 
were selected. Southern blotting and PCR assays confirmed the deletion of the abrC3 
gene in S. coelicolor M145. 
RNA isolation and DNA microarrays analysis  
For RNA extraction from S. coelicolor parent strain and ∆abrC3 mutant strains, 160 mL 
of NB media was inoculated in 500 mL baffled flasks with 4 x 106 spores/mL and 
incubated at 30 ºC for 36, 48, and 60 h. Two biological replicates and three technical 
replicates were used for each time-point. Prior to RNA isolation using a modified 
version of mirVana miRNA Isolation kit protocol (Life Technologies), cells from 20 
mL of culture were harvested and suspended in RNA-protect Bacteria Reagent 
(Qiagen). Following mycelial lysis with lysozyme (15 mg/ml in TE at room 
temperature), three vol. of RLT buffer from the RNeasy mini plus kit (Qiagen) were 
added and mycelia were disrupted using a TissueLyser (Qiagen) for 4 min. The lysate 
was clarified by centrifugation, extracted twice with phenol/chroroform and once with 
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chloroform and applied to a gDNA eliminator filter (RNeasy mini Plus, Qiagen) to 
remove any contaminating DNA. After this step 1.25 vol of 100 % ethanol were added 
and the total RNAs (including small RNAs) were purified through the mirVANA 
columns following the manufacturer’s recommendations. The quality and concentration 
of RNA were assayed using the Bioanalyzer 2100 system and spectrophotometric 
assays (Agilent and Nanodrop ND1000, respectively).  
The S. coelicolor IJISS 105K microarray used for ChIP-chip and high-resolution 
transcriptome analysis, was designed by the Functional Genomics Laboratory of Surrey 
University (UK) in collaboration with Oxford Gene Technology (UK), and 
manufactured by Agilent. They comprise almost 105,000 unique 60-mers with an 
average genome spacing of 35 nucleotides. The 105K probes are designed to cover the 
coding strands of all known protein coding genes and both strands of all intergenic 
regions. A cDNA versus reference gDNA microarray two-colour experimental design 
was utilised for the transcriptomic comparison of S. coelicolor M145 and ∆abrC3. All 
Cy3-cDNA and Cy5-gDNA labelling reactions and hybridisation assays were 
performed according to the recommendations described in 
http://www.surrey.ac.uk/fhms/microarrays/Downloads/Protocols/index.htm 
All hybridised arrays (expression and ChIP-chip) were scanned using an Agilent 
Technologies microarray scanner and resultant images were analysed using Agilent 
Technologies Feature Extraction software (version 9.1.3.1.) with local background 
correction.  
Raw gene expression data were normalised within the statistical computing 
environment R using the LIMMA package (32-34) global median within-array 
normalization, followed by the ‘scale’ across-array normalization was applied. Probes 
that were flagged as poor quality by Agilent Feature Extraction were removed from the 
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analysis. A gene’s expression was calculated by averaging across all remaining good 
quality probes that target the annotated coding sequence. Expression data sets were 
analysed using rank products analysis via RankProdIt (http://strep-
microarray.sbs.surrey.ac.uk/RankProducts), a web-interactive analysis tool (35). 
Differentially expressed genes were identified as having a pfp (probability of false 
prediction) value less than or equal to 0.15, equal to a false discovery rate of 
approximately 15 % and at a level that has been experimentally validated (in this study) 
and others (e.g. (36). A BED formatted track with the average Log2 expression data to 
be visualised across the chromosome using the UCSC microbial gene browser 
(http://microbes.ucsc.edu/) was generated using in-house Perl scripts. All data are 
MIAME compliant and the raw and normalized data have been deposited in 
ArrayExpress (accession number E-MTAB-1453). 
 
qRT-PCR  
Real-time quantitative RT-PCR (qRT-PCR) was used to validate the microarray data. 
Specific primers and probes for the tested genes were designed using the Primer3 web-
based tool (Table S2). Five-µg RNA samples were treated with RNAase-free DNaseI 
(Promega) according to the manufacturer instructions. One µg of the resulting RNA was 
used as template for cDNA synthesis using iScript Reverse Transcription Supermix for 
RT-qPCR (Bio-Rad) in 20 μl reaction volumes. The samples were diluted 1:1 with 
distilled water and 5 μl was used in the quantitative PCR reaction with 10 pmol of 
forward and reverse primer, 2.5 pmol of FAM/TAMRA dual-labelled specific probe, 
and 12.5 μl SsoFastTM Probes Supermix with ROX master mix (Bio-Rad) in a final 
volume of 25 μl. Each assay was performed in duplicate using CFX96 Touch™ Real-
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Time PCR Detection System (Bio-Rad). Control PCRs were included to verify that 
there was no DNA contamination (without RT, enzyme negative control). Relative 
quantification of gene expression was performed by the ∆∆Ct method, a comparative 
qPCR data analysis (37) in which, the Ct values of the genes of interest obtained from 
two different experimental RNA samples (parent strain and mutant) are directly 
normalized to the Ct values of a housekeeping gene (gene control) in the same samples. 
First, the difference between the Ct values of the gene of interest between parent and 
mutant strains (∆Ct1) and difference of Ct values of the housekeeping gene between 
both strains (∆Ct2) are calculated for each experimental sample. Then, the difference in 
the ∆Ct values between the gene of interest and control gene (∆Ct1-∆Ct2 = ∆∆Ct) is 
calculated. The fold-change in expression of the gene of interest between the two 
experimental samples (parent strain and mutant) is then equal to 2-∆∆Ct. The gene hrdB 
(SCO5820) was the internal control used to quantify the relative expression of the target 
genes, since its expression level remained constant in all the conditions analyzed by 
microarray. The expression ratios measured by microarrays and by qRT-PCR assay 
were plotted, and the linear correlation coefficient was calculated (y = 1.60x – 0,09; R2 
= 0.93) (Table 3).  
 
ChIP-chip analysis 
For Chromatin Inmunoprecipitation (IP) three aliquots of 20 mL from the same cultures 
used in the microarray gene expression analysis were taken (S. coelicolor M145 and 
∆abrC3 mutant strains incubated at 30 ºC for 36, 48, and 60 h). These samples were 
treated with formaldehyde (Sigma) at a final concentration of 1 %. Crosslinking was 
allowed to proceed for 30 min at 30 ºC. Glycine, at a final concentration of 0.5 M was 
added to stop the crosslinking for a further 5 min at 30 ºC. Mycelium was harvested by 
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centrifugation and frozen at -20 ºC. Chromatin of average size range 300-600 bp was 
obtained as described in Bucca et al (38). Chromatin IP was carried out as described 
before (38) using purified rabbit polyclonal antibodies against AbrC3 obtained in our 
laboratory. The IgG fraction containing anti-AbrC3 polyclonal antibodies and the 
fraction from preimmune serum from the same rabbit used for immunisation was 
purified by affinity chromatography using CNBr activated Sepharose 4B (Sigma). The 
chromatin purified from S. coelicolor M145 and ∆abrC3 mutant strains was sonicated 
to obtain an average size range of 300-600 bp. DNA samples were immunoprecipitated 
with either AbrC3 antibodies (abIP) or mock control (NoIP), purified, labelled with Cy3 
or Cy5-dCTP respectively and hybridized to 105K arrays as described above. Two 
biological replicates were hybridized such that the AbIP/NoIP samples from each of the 
two replicates were labeled in opposite dye orientations to control for dye bias. Arrays 
were scanned and processed as described above. 
The raw data were normalized within R (as above) using the across-array scale function 
of the LIMMA package only. Again, poor quality probes were filtered out from 
downstream analysis. The data analysis was carried out essentially as described by 
Allenby et al. (39). Significant probes (p < 0.05) defined on the basis of a non-
parametric t-test run with ‘multtest’ and ‘pnorm’ (within R) were plotted as ratio of 
[(parent strain Ab IP/mock IP) / (∆abrC3 Ab IP/mock IP)]. The probes most 
differentially-enriched for AbrC3 binding between the parent strain and the mutant were 
selected from the right tail of the distribution. Probes within 3 kb (based on their 
annotated genomic location) of each other were ‘grouped’ and genomic regions of 
interest were those in which at least two enriched probes were found. Finally, tracks 
(BED files) to visualise the data across the chromosome using the UCSC microbial 
genome browser (http://microbes.ucsc.edu/) were generated using in-house Perl scripts. 
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The raw and normalized ChIP-chip data have been deposited in ArrayExpress 
(accession number E-MTAB-1451). 
 
Western blot assays 
Total protein extracts were obtained from 5 mL samples (in triplicate) of the cultures 
used for the global analysis described above. The proteins were resolved in SDS-PAGE 
(15 % polyacrylamide in a MiniProtean II system, BioRad). After transfer to Inmobilon-
P (Millipore) the proteins were reacted with pre purified polyclonal 1:100000 dilution 
of anti-AbrC3. AbrC3 was detected by chemiluminescence with ECL western blotting 
detection reagents following the manufacturer’s instructions (GE Healthcare) using 
horseradish peroxidase-coupled anti-rabbit secondary antibody. 
 
In vitro DNA-binding assays  
Gel-shift assays were conducted using DNA fragments containing the intergenic region 
(up to -400 bp from the translational start point) plus 100 (+ 100 inside the ORF) were 
amplified using the corresponding primers in a PCR reaction (Table S2). These 
fragments were 5’-radiolabelled with T4 polynucleotide kinase in the presence of [γ-
32P]-dATP, and the unreacted [γ-32P]-dATP was removed using Illustra ProbeQuant TM 
G-50 Micro Columns (GE HealthCare, USA). The purified proteins were incubated in 
Tris-HCl 50 mM pH 7, MgCl2 25 mM, NaCl 0.1 M at 30 ºC for 30 min, prior to the 
binding. Then, different concentrations of the proteins were incubated with the labelled 
DNA probes (10 fmol) in binding buffer (Tris-HCl 10 mM pH 7.8, DTT 2 mM, NaCl 
150 mM, glycerol 10 % and 45 ng of sheared salmon sperm DNA) for 30 min at 30 ºC. 
Protein bound DNA and free DNA were resolved on 5 % acrylamide gel in 0.5 X TBE 
buffer (Tris 44,5 mM, boric acid 44,5 mM, EDTA 1 mM pH 8) at 4º C. The gel was 
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exposed overnight and autoradiography revealed. As control, unlabelled specific probe 
(S) (100-fold molar excess) or non-specific competitor DNA (N) (100-fold molar excess 
of sheared salmon sperm DNA) were added to the reaction mixture. Also a BSA protein 
binding reaction (4 µM) was conducted as a control to demonstrate the specificity of the 
EMSAs. 
 
Identification of the putative AbrC3 binding site 
The Regulatory Sequence Analysis Tools (RSAT) “consensus” alignment  
(http://rsat.ulb.ac.be/) was used to identify putative DNA conserved sequences in the 
upstream regions (with respect to the annotated translation start codon) of the AbrC3 
target genes (including 100 bp into the respective ORF), identified from the ChIP-chip 
experiment.  
The functionality of the conserved ten-base sequence, identified with RSAT consensus 
alignment, was demonstrated by eliminating it from the actII-ORF4p p. The elimination 
of this sequence was achieved using overlapping PCR. As a first step, PCR amplicons 
were made using primers SRG95/SRG97 and SRG96/SRG90, respectively (Table S2). 
Using both resulting fragments as templates, a second PCR was conducted using 
oligonucleotides SRG95/SRG90. The final fragment, with EcoRI/PstI sites in the ends, 
was cloned into the pGEM T-easy plasmid. The elimination of the consensus binding 
sequence from the absR1p was performed by PCR amplification of the region with the 
oligonucleotides SRG-116/SRG073 (Table S2). 
 
Antibiotic production measurements 
Production of ACT in liquid cultures was determined measuring A640 (ε640= 25320) in 
the supernatant of samples treated with 1N KOH overnight at 4 ºC and centrifuged 
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(15000 g, 10 min). The experiments were all performed in triplicate and the dry weight 
of samples at different times was measured to monitor culture growth. 
Chromatographic analysis  
Liquid cultures were centrifuged and supernatants and cell pellets were extracted 
separately. The supernatants were extracted twice with an equal volume of ethyl acetate 
containing 1% formic acid. The cell pellets were extracted with acetonitrile. In each 
case, the solvent was evaporated and the residue re-dissolved in a small volume of a 
mixture of dimethyl sulfoxide and methanol (50:50). These samples were 
chromatographed as previously described (40). 
 
RESULTS 
Influence of the AbrC3 RR in antibiotic production in Streptomyces  
The S. coelicolor ∆abrC3 mutant strain was generated using the PCR-targeting 
approach described by Gust et al. (31), which replaced the entire coding region of the 
gene with an apramycin resistance cassette (see Materials and Methods). Phenotypic 
analysis of growth and antibiotic production of the parent strain (M145 strain), ∆abrC3 
and the triple mutant ∆abrC1/C2/C3, previously described (13), revealed significant 
differences among the three strains (Figure 1A). ACT and RED production were highly 
diminished in both the triple and single mutant compared to the parent strain on nutrient 
agar medium. In contrast, CDA production in the mutant lacking only the response 
regulator, ∆abrC3, was unaffected while it was clearly diminished in the triple mutant. 
A delay in morphological differentiation on solid medium was also observed in both 
mutants. When the strains were grown in liquid nutrient broth (NB) the ∆abrC3 mutant 
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produced almost no ACT. Complementation of the ∆abrC3 mutant with the integrative 
plasmid pSET152-abrC3 restored ACT production to almost parent strain levels (Figure 
1B). Both mutants and the parent strain produced similar growth curves (e.g., Figure 
S1A) indicating that growth per se was not compromised in the mutant strains. 
Complementation with pSET152-abrC3 was also tested on solid medium (NA). ACT 
production and morphological differentiation were complemented and there was a 
partial complementation of RED production (Figure 1B). It was noted that ACT 
production on solid medium was found to be higher in the complemented strain than in 
the parent strain harbouring the empty plasmid; pSET152-derivates tend to exist as 
tandem duplications in the genome (CPS, unpublished data) and it is therefore 
conceivable that an enhanced level of AbrC3 is responsible for the elevated ACT 
production.  
It is noteworthy to mention that quantification of ACT production from M145 cells 
transformed with abrC3 moderately overexpressed from the low copy number plasmid, 
pHJLabrC3 plasmid, showed 33% more ACT production at five days compared to the 
plasmid control, pHJL401 (Figure 2). This result was consistent with AbrC3 acting as a 
positive regulator of the ACT gene cluster and offers the possibility of using this low 
copy number plasmid to enhance antibiotic production. Indeed, when pHJLabrC3 was 
introduced into the S. lividans 66 strain, the normally silent ACT pathway was induced 
to even higher levels than in S. coelicolor (Figure 2). 
 
Effects of abrC3 deletion on the S. coelicolor transcriptome 
Comparison of genome-wide mRNA abundances between the parent strain S. coelicolor 
M145 and its congenic ∆abrC3 mutant was performed. Samples from 36, 48, and 60 h 
growth (Figure S1-A) were taken and antibiotic production at these time points was 
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assessed by HPLC. As shown in Figure S1-B, at 60 h growth there was an ACT 
production peak in the parent strain but not in the mutant strain, in both the supernatant 
and cell extract fractions. Likewise, RED production was only observed in parent strain 
cell extracts. In addition, the level of AbrC3 protein in the parent strain and its absence 
in the mutant ∆abrC3 strain at the three sampling points used in this study was 
confirmed by Western blotting using anti-AbrC3 antibodies (Figure S1-C).  
Total RNA samples from the ∆abrC3 mutant and the parent strain cultivated at 36, 48, 
and 60 h in NB medium were labelled and hybridized to 105K × 60-mer high density 
whole genome S. coelicolor IJSS DNA microarrays as described by Lewis et al. (41) 
(see Materials and Methods). Analysis of the DNA microarray data from two 
independent experiments revealed that only 32 genes were down-regulated and eight 
genes were up-regulated at a statistically significant level (Benjamini and Hochberg 
corrected p-values <0.005 and pfp <0.15 (pfp: probability of false prediction)) (see 
Tables 1 and 2). Of the 33 genes that showed a significantly reduced expression in the 
mutant strain, 16 corresponded to the entire act cluster, including actII-ORF4 
(SCO5085), which encodes the SARP pathway-specific regulator of the act cluster 
(Table 1). Three other significantly down-regulated genes encode regulatory proteins 
and were previously related to antibiotic regulation, sIHF (SCO1480) (15, 16), afsS 
(SCO4425) (17, 18), and absR1 (SCO6992) (19). An additional gene encoding a 
putative transcriptional regulator with a helix-turn-helix motif, SCO1839, and two genes 
involved in morphological development, wblE (SCO5240, encoding an extra-
cytoplasmic function sigma factor (20, 21)) and bdtA (SCO3328, encoding a putative 
transcription factor regulated by BldD, and that forms an operon with SCO3327 (22, 
23)) were also significantly down-regulated. The acdH gene (SCO2779) encoding an 
acyl-CoA dehydrogenase involved in branched amino acid catabolism in S. coelicolor 
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and S. avermitilis (42) and SCO3218, a gene of unknown function located in the cda 
gene cluster, were also significantly down-regulated in the mutant (Table 1). Among the 
eight genes significantly up-regulated were the ribosomal protein gene, rplP (SCO4709) 
and chpE (SCO1800) (43) (see Table 2). 
Several of the differentially expressed genes were selected for independent validation 
by quantitative real time PCR (qRT-PCR) (Table 3). These included down regulated 
genes: acdH (SCO2779) acyl-CoA dehydrogenase, absR1 (SCO6992) activator of 
secondary metabolism, a sigma-like protein gene afsS (SCO4425), and the specific 
regulator of the ACT cluster, actII-ORF4 (SCO5085). We also analyzed the expression 
levels of one of the genes differentially up-regulated in the mutant that encodes the 50S 
ribosomal protein L16 rplP (SCO4709). Moreover, we included both histidine kinase 
genes of the TCS, abrC1 and abrC2 (SCO4598 and SCO4597), in order to confirm their 
non-differential expression levels. A good correlation of transcript measurements from 
the microarray data and the qRT-PCR data (yielding a correlation regression coefficient 
of 0.93) was obtained (Table 3). Note that the validation of differential expression for 
SCO4709 confirms the use of 0.15 as a suitable pfp threshold for determining 
significance, similar to that found in other expression based studies (e.g. (36)). 
 
In vivo identification of AbrC3 targets on the S. coelicolor genome  
The genes exhibiting a marked AbrC3-dependent change in expression could be directly 
regulated by AbrC3 or could be regulated by transcription factors downstream of AbrC3 
in a possible regulatory cascade. Hence, to identify genes directly regulated by AbrC3, 
by interaction with their respective promoter regions, a genome-wide ChIP-chip 
approach was undertaken. Samples from the same cultures and time-points used for the 
transcriptomic analysis (above), were treated with formaldehyde to cross-link proteins 
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to DNA and subjected to chromatin immunoprecipitation with either purified anti-
AbrC3 antibodies or mock controls (see Materials and Methods). The 
immunoprecipitated DNA from each strain was labelled with Cy3 or Cy5 in a dye-
balanced direct comparison experimental design and hybridized to the above mentioned 
105K S. coelicolor microarrays (see Materials and Methods). Two biological replicate 
experiments were conducted and significantly enriched genomic binding regions in the 
parent strain relative to the ∆abrC3 mutant were identified. We identified 617, 520, and 
458 AbrC-enriched (AbrC3 DNA targets bound at significant higher levels when 
comparing parent strain to the mutant) regions from chromatin isolated at 36 h, 48 h, 
and 60 h of growth, respectively. The genes with higher enrichment ratio are 
summarized in Table 4 and the overlapping targets in ChIP-chip and transcriptome 
analyses in Table 5. 
This analysis demonstrates that the AbrC3 protein is able to bind in vivo to the promoter 
of the pathway-specific regulator gene of the ACT cluster, actII-ORF4p, (SCO5085) 
(Table 4 and 5) at 36 h with high efficiency. No binding was detectable at 48 h or 60 h. 
This result suggests that the down-regulation of the act gene cluster (Table 1) is due to 
the direct regulation of actII-ORF4 exerted by AbrC3 at around 36 h culture time.  
Efficient binding of AbrC3 to its own promoter abrC3p (SCO4596) at 60 h was also 
observed (Table 5), indicating that AbrC3 is an autoregulator. No binding to the 
promoters of the histidine kinase-encoding genes of the AbrC system (abrC1 and 
abrC2), nor differential expression of these two genes under the experimental 
conditions used, was observed (Table 3). 
In vivo binding of AbrC3 to several of the promoters of the genes previously identified 
as down-regulated was observed and therefore their expression is very likely to be 
directly controlled by AbrC3 (Table 5). Weaker AbrC3-enrichment was observed 
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upstream of genes SCO1480 (sIHF), SCO1550, the regulator SCO1839, the acyl-CoA 
dehydrogenase AcdH (SCO2779), and the transcription factor WblE (SCO5240), and no 
binding at all was observed for three of the differentially expressed genes identified in 
our transcriptome analysis: SCO0682, SCO3218, and afsS (SCO4425) (data not shown). 
We hypothesize that these genes could be regulated by factors downstream of AbrC3 in 
a possible regulatory cascade, or additional transcription factors/co-factors bound to the 
promoter regions blocked access of the anti-AbrC3 antibody, yielding false negatives 
(see, for example, (39)).  
Among the significantly up-regulated genes, we could only detect binding of AbrC3 to 
the putative promoters of the rplP (SCO4709) and SCO6809 genes (Table 5), 
suggesting that the other six up-regulated genes may be regulated by factors 
downstream.  
Electrophoretic mobility shift assays (EMSAs) were conducted to test the in vitro 
binding capacity of the protein to the DNA sequences upstream of the corresponding 
genes that showed AbrC3-binding in vivo. DNA fragments comprising intergenic region 
(up to -400 bp from translation start point) plus 100 bp inside the ORF (+100) were 
used to perform the experiments and were so on called promoters* (SCOXXXXp). Most 
of the identified targets that were bound in vivo by the AbrC3 protein (Table 5) were 
also able to be bound in vitro with high specificity: actII-ORF4p, abrC3p, SCO0736p, 
absR1p, and SCO6809p (Figure 3A, 3B, 3C, 3D and 3H). The promoters* of SCO2113 
and bdtA were bound with less specificity (Figure 3E and 3F) and some putative 
promoters*, such as SCO4709p, did not yield mobility shifts in vitro (Figure 3G). 
Competition experiments to verify the specificity of AbrC3 binding, to each promoter*, 
were conducted by adding different amounts of the corresponding unlabelled DNA or 
different amounts of sheared salmon sperm DNA to the binding reaction. 
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Identification of a putative consensus AbrC3 binding site 
Aligning the 500 bp upstream sequences (including the first 100 bp of the respective 
ORFs) of genes enriched for AbrC3 in the ChIP-chip and EMSA analyses using the 
Regulatory Sequence Analysis Tools consensus alignment (http://rsat.ulb.ac.be/) 
identified a minimal consensus-binding site for AbrC3. A common 10 bp sequence (5’-
GAASGSGRMS-3’) was present in all of the putative promoters of the identified target 
genes and was absent in the ones that did not yield mobility shifts in vitro, such as 
SCO4709p (Figure 4A). This putative AbrC3-binding sequence was present within the 
ORF of actII-ORF4, in the positions +72/+81 (from the translation start codon), near 
one of the described target sequences of the regulator AtrA (44) (Figure 5). This 
sequence was also found in 23 out of 30 of the genes identified by ChIP-chip (Table 4).  
The functionality of this putative AbrC3-binding sequence was demonstrated by 
EMSAs using different fragments of the actII-ORF4p or deleting the putative binding 
sequence (Figure 4B). Only the whole promoter* region (fragment 1 used also in Figure 
3), or a 3ʹ′ part of the promoter* that included the ten-base sequence generated a 
mobility shift in the presence of the AbrC3 protein (Figures, 4B panels 1 and 4). 
Conversely, the mobility shift did not take place when the ten-base sequence was 
removed (see Materials and Methods) (Figure 4B panel 5); controls used to demonstrate 
the specificity of AbrC3-binding to the 3ʹ′ segment of the promoter* (fragment 4) are 
shown in Figure 4C. This result clearly indicated that the sequence (5’-
GAAGGCGACC-3’) was essential in the direct regulation of the actII-ORF4 expression 
by the AbrC3 regulator.  
The importance of this sequence in the binding of AbrC3 was also demonstrated by 
EMSA with absR1p, another direct target of this regulator. The elimination of the 
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proposed binding-sequence (5’-GAAGGGGACG-3’) originated the sequence 
absR1pDel unable to bind AbrC3, and therefore the shifted band was not observed. 
(Figure S2). 
Moreover, EMSAs were performed using shorter DNA probes consisting in a 50 bp 
labeled oligonucleotide (resulted from annealing two complementary long 
oligonucleotides SRG119/120 (Table S2)) corresponding to a small fragment from 
actIIORF4p and containing the predicted binding sequence (probe 1) and also another 
artificial labeled oligonucleotide with the same size containing this sequence but 
surrounded by foreign DNA (probe 2: annealing of oligonucleotides SRG121/122 
(Table S2)). The results (Figure S3) showed the ability of AbrC3 to bind specifically to 
probe 1 and also to the artificial probe 2. Therefore these 10 nucleotides (5’-
GAAGGCGACC-3’) were enough to recruit the protein. 
DISCUSSION 
AbrC3 directly regulates actII-ORF4 expression 
An integrated global ChIP-chip and transcriptome analysis of parent strain S. coelicolor 
and an abrC3 mutant derivative has identified the regulon of the response regulator 
AbrC3. actII-ORF4, the pathway-specific regulator of ACT, is one of its direct targets 
as corroborated by EMSA in vitro. A 10 bp sequence, 5’-GAASGSGRMS-3’, identified 
by RSAT consensus alignment of the putative promoters* targeted by AbrC3 defines 
the AbrC3 binding site. In the case of actII-ORF4, the binding sequence (5’-
GAAGGCGACC-3’) is found within the ORF at the position +72/+81 (from the 
translational starting ATG) (Figure 5). It is not the first time that a transcriptional 
regulator-binding site is found within the actII-ORF4 coding sequence; there are two 
other regulators, AtrA and Crp, whose binding sites are in position +45/+69 (44) and 
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+24/+38 (45), respectively. DNase footprinting assays using selected AbrC3 associated 
sequences failed to yield a DNase-protected region (data not shown); we consider that 
the observed poor solubility of AbrC3 in vitro may account for the incomplete shifting 
of template DNA obtained in the EMSAs and for our failure to observe a footprint. 
Nevertheless, this consensus sequence has been shown indispensable for AbrC3 binding 
to the actII-ORF4p (Figure 4) and for another of its targets (absR1p) (Figure S2). We 
speculate that binding of AbrC3 to the actII-ORF4p at 36 h may be necessary for the 
recruitment of other regulators and that the binding of these is necessary for the first 
steps of actII-ORF4 expression: after this initial ‘recruitment’ the regulators are 
subsequently released from the promoter* to allow expression of downstream genes. 
The expression of the ACT-specific pathway regulator actII-ORF4 is under the control 
of different regulatory proteins that respond to diverse signaling routes in S. coelicolor 
such as PhoP/R (46) and RapA1/A2 (47), LAL regulators SCO0877 and SCO7173 (48), 
ECF SigT (49), among others (reviewed by van Wezel and McDowall (3)). To date, 
demonstration of the direct binding of transcription factors to the actII-ORF4 promoter 
region is limited (Figure 5). In vitro binding assays (EMSAs) have shown that the AtrA 
protein binds to the actII-ORF4 promoter (44). More recently, DNA affinity capture 
assays have shown the capability of four more proteins (SCO0310, SCO3932, 
SCO5405 and AdpA) to bind to the actII-ORF4 promoter (15). Among the TCSs 
implicated in antibiotic production only AbsA2 has, thus far, been shown to bind to the 
actII-ORF4 promoter in vivo (50). Very recently, EMSAs have demonstrated the in 
vitro binding of the TCSs DraR/K and AfsQ1/Q2 to the actII-ORF4 promoter (51, 52). 
Control of secondary metabolism by the global regulator Crp has also recently been 
described and Crp binding to actII-ORF4 detected by ChIP-chip, being both of the two 
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binding sites described within the ORF, in positions +24/+38 and +234/+248 (Figure 5) 
(45). 
AbrC3 regulon 
The putative binding sequence (5’-GAASGSGRMS-3’) defined in this work is present 
in 23 out of 30 genes with the highest binding enrichment (WT AbIP/NoAbIP vs 
∆abrC3 AbIP/NoAbIP enrichment ratio obtained in the ChIP-chip assay) (Table 4). The 
position of the putative binding sequence is typically upstream of the respective ORF 
suggesting regulation of the gene downstream of the binding site. However, in some 
cases the target sequences are within the coding sequences. This feature is coincident 
with data described previously in the study of the regulation exerted by the protein Crp 
where more than 50 % of all Crp-associated sequences were mapped within ORFs (45). 
The regulatory role of these sequences located inside the ORFs is not clear and in a 
recent study, using ChIP-seq and ChAP-seq technologies to characterize the AdpA 
regulon, it was found that approximately 75 % of the in vivo AdpA-binding sites 
apparently have no function in the regulation of gene expression (53).  
Conversely, it is also possible that some bona fide AbrC3 targets were missed in this 
study because the antibody does not recognize the epitopes when AbrC3 is one of 
several transcription factors bound to the promoter regions. It is known that false 
negatives can occur in ChIP-chip studies (38).  
 
Pleiotropic regulation by the abrC TCS 
The pleiotropic phenotype of the triple ∆abrC1/2/3 mutant (13) shows relative 
differences (decreased CDA production) when compared to the phenotype of the RR 
gene deletion mutant, ∆abrC3. This result suggests that other RRs may be controlled by 
the kinases of this TCS such as the orphan RR SCO2281 proposed by Wang et al to be 
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recognized by AbrC2 (54). It is known that the biosynthetic RED genes are expressed 
early, so the existence of AbrC3 direct regulation to the promoter regions of redD or 
redZ cannot yet be excluded with the experimental conditions tested. If the RED cluster 
regulation by AbrC3 is indirect, this could be exerted through the regulatory cascade 
triggered by AfsS, that is one of the indirect AbrC3 targets (17, 18), or by sIHF, down-
regulated in ∆abrC3 and able to bind to the redD and redZ promoters (15, 16).  
Several transcriptional regulators, whose encoding genes were down-regulated in our 
study could be responsible of the morphological phenotype observed in the ΔabrC3 
mutant: sIHF that also binds to the bldD promoter, a key regulator of development in S. 
coelicolor (16); the extracytoplasmic function sigma factor, WblE (20, 21); and BdtA a 
putative transcription factor regulated by BldD involved in morphological 
differentiation (22, 23).  
ChIP-chip assays demonstrated that AbrC3 is an autoregulator. No differential 
regulation between the wild type strain and the AbrC3 mutant of the two kinase-
encoding genes of the AbrC TCS system was identified in our ChIP-chip or 
transcriptome analysis.  
A summary of the main interactions within the AbrC3 regulon deduced from our global 
in vivo analyses (ChIP-chip and transcriptome analysis) is illustrated in the model 
depicted in Figure 6. We have observed a global positive effect on secondary 
metabolism, mainly on the ACT cluster, and morphological differentiation through the 
direct interaction of AbrC3 with the different genes mentioned above. This activation 
could also be facilitated by a negative control of AbrC3 on primary metabolism through 
ribosomal proteins such as RplP. Indeed, another gene involved in primary metabolism, 
acdH, is down-regulated in the ∆abrC3 mutant; this gene encodes an Acyl-CoA 
dehydrogenase involved in biosynthesis of precursors of ACT and RED and that could 
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explain the positive regulation of this gene by AbrC3. Besides, Wang et al. have just 
reported in vitro evidence that abrC3 is a target of AfsQ1 and that it positively regulates 
its expression. This suggests that the function of AfsQ1/Q2 is at least partly mediated 
via the AbrC1/C2/C3 system, further illustrating the complexity of the regulatory 
network governing antibiotic production (Figure 6) (51, 52).  
The emergence of new antibiotic resistant isolates makes new antibiotic discovery and 
the improvement of their production major challenges for microbial biotechnology. 
Widening our knowledge regarding TCS involvement in antibiotic synthesis regulation 
can contribute to the rational design of new hyper-producer host strains through genetic 
manipulation of those complex systems. Moreover, strategies involving TCS could be 
used to unveil new antimicrobial molecules that are not normally produced under 
laboratory culture conditions. 
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SUPPLEMENTARY DATA 
Figure S1: Phenotypic features of cultures used for ChIP-chip and transcriptome 
analysis. A) Growth curves of parent strain M145 and ∆abrC3 strains in NB medium at 
30 ºC. The cultures times selected for RNA isolation are encircled. B) HPLC profiles of 
60 h samples showing ACT and RED antibiotic production in M145 (black) and 
∆abrC3 (grey) strains. C) Western blot of the samples selected (36, 48 and 60 hours) in 
two biological duplicates using anti-AbrC3 antibodies. 
Figure S2: EMSA of AbrC3 protein with absR1p and absR1pDel (the same region 
without the putative proposed binding-sequence, 5’- GAAGGGGACG -3’).  
Figure S3: EMSA of AbrC3 protein with actII-ORF4 50-bp oligonucleotide containing 
the proposed binding-sequence (5’-GAAGGCGACC-3’) (Probe 1) and an artificial 50-
pb oligonucleotide including this sequence (5’-GAAGGCGACC-3’) but surrounded by 
foreign DNA (Probe 2).  
Table S1: Plasmids and cosmids used in this work 
Table S2: Oligonucleotides used in this work  
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TABLES  
TABLE 1 - Selected genes significantly down-regulated in the ∆abrC3 mutant relative 
to parent strain, M145 (p-value< 0.005 and/or pfp*<0.15) 
SCO/name Function p-value pfp 
Fold 
change 
Time 
(hours) 
5071 Hydroxylacyl-CoA dehydrogenase 0 0.002 -1.77 48 
5072 Hydroxylacyl-CoA dehydrogenase 0 0 -2.13 48 
5073 Putative oxidoreductase 0 0 -2.09 48 
5074 Putative dehydratase 0 0 -3.25 48 
5075/ORF4 Putative oxidoreductase 0 0 -2.23 48 
5077/actVA2 Hypothetical protein 0 0.001 -1.99 48 
5078/actVA3 Hypothetical protein 0 0 -2.28 48 
5079/actVA4 Conserved hypothetical protein 0 0 -2.28 48 
5080/actVA5 Putative hydrolase 0 0 -2.25 48 
5081/actVA6 Hypothetical protein 0 0 -2.59 48 
5085/actII-ORF4 Actinorhodin cluster activator protein 0 0 -2.85 48 
5086/actIII Ketoacyl reductase 0 0 -2.80 48 
5087/actIORF1 
Actinorhodin polyketide beta-ketoacyl synthase alpha 
subunit 0 0.008 -1.83 48 
5088/actIORF2 
Actinorhodin polyketide beta-ketoacyl synthase beta 
subunit 
0 0.003 -1.92 48 
5089/actIORF3 Actinorhodin polyketide synthase acyl carrier protein 0 0 -3.11 48 
5090/actVII 
Actinorhodin polyketide synthase bifunctional 
cyclase/dehydratase 0.0002 0.060 -1.63 48 
0045 Hypothetical protein 0.0005 0.127 -1.23 48 
0682 Hypothetical protein SCF15.03c 0.0001 0.053 -1.25 48 
0736 Putative secreted protein 0 0.019 -1.45 60 
1480/sIHF Streptomyces Integration Host Factor 0.0003 0.090 -1.28 48 
1550 Putative small membrane protein 0.0002 0.070 -1.35 36 
1839 Putative transcriptional regulator 0.0005 0.120 -1.40 36 
2113/bfr Putative bacterioferritin 0.0001 0.050 -1.24 48 
2779/acdH Acyl-CoA dehydrogenase 0.0006 0.145 -1.27 36 
3218 Putative small conserved hypothetical protein 0 0.018 -1.39 36 
3327 Hypothetical protein 0.0002 0.051 -1.41 60 
3328/bdtA Hypothetical protein 0.0002 0.055 -1.47 60 
4425/afsS Sigma-like protein 0 0.001 -1.83 48 
5240/wblE Hypothetical protein 0.0007 0.158 -1.36 48 
5915 Fatty acid desaturase 0.0003 0.081 -1.39 36 
6205 Putative threonine dehydrogenase 0.0007 0.158 -1.43 48 
6992/absR1 Regulatory protein 0.0001 0.056 -1.57 60 
* pfp: probability of false prediction 
 
  
 36 
 
TABLE 2 - Selected genes up-regulated in the ∆abrC3 mutant relative to the parent 
strain, M145 (p-value< 0.005 and/or pfp*<0.15) 
SCO/name Function p-value Pfp Fold change Time 
1800/chpE Putative small secreted protein 0.0001 0.145 1.12 48 
2605 Hypothetical protein SCC88.16 0.0002 0.140 1.36 36 
4187 Putative membrane protein 0 0.040 1.52 36 
4709/rplP 50S ribosomal protein L16 0.0001 0.119 1.16 36 
6329 Hypothetical protein SC10H5.05 0.0001 0.115 1.38 60 
6809 
Putative integral membrane transport 
protein 
0.0001 
0.124 1.41 60 
7665 Hypothetical protein 0.0002 0.131 1.07 36 
7801 Putative membrane protein 0.0002 0.131 1.39 60 
* pfp: probability of false prediction 
 
 
TABLE 3. qRT-PCR validation of five differentially expressed genes identified from 
microarray data. Linear regression fit analysis was applied and correlation 
coefficient used to validate the data (y = 1.60x – 0,09; R2 = 0.93) 
SCO/name Function 
Expression ratios (fold change)a 
Microarray  RT-qPCR 
2779/acdH Acyl-Coa dehydrogenase -1.27 -2.13 
4425/afsS Sigma like protein -1.83 -3.06 
4597/abrC2 Sensor kinase -1.085 -1.12 
4598/abrC1 Sensor Kinase -1.04 -1.08 
5085/actII-ORF4 ACT cluster activation protein -2.85 -3.90 
6992/AbsR1 Regulatory protein -1.57 -3.65 
4709/rplP 50S ribosomal protein L16 1.16 2.11 
a parent strain M145 versus ∆abrC3  
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TABLE 4. AbrC3 ChIP-chip targets selected by their high enrichment ratio 
Regulated 
genea 
Enrichment 
ratiob 
Predicted function of regulated 
gene 
Timec 
Predicted binding site 
sequenced 
SCO0167 2.45 Conserved hypothetical protein SCJ1.16c 36 354 GAAGGGGGCG 363 
SCO0951 2.22 Putative transport system permease protein 36 -329 GGTCGCCTTC -318 
SCO1391 5.44 crr ,phosphoenolpyruvate-protein phosphotransferase 48 1113 GAAGGCGGCG 1122 
SCO3020 4.22 Putative integral membrane protein 48 Not found 
SCO3263 2.60 Conserved hypothetical protein 36 -240 GTTCGCCTTC -231 
SCO3334 5.70 trpS, tryptophanyl tRNA synthetase 48 -387 GGCCGCGTTC -378 
SCO3590 2.54 vanR, putative TCS response regulator 36 Not found 
SCO3992 2.45 Hypothetical protein 36 Not found 
SCO4075 6.32 ragA, ABC transport protein, ATP-binding subunit 48 Not found 
SCO4123 5.02 Putative TCS response regulator 48 -674 GAACGCGACC -665 
SCO4596 2.24 abrC3, TCS response regulator 60 -137 CTTCCCGTTC -128 
SCO4630 2.78 Hypothetical protein 36 Not found 
SCO5085 2.23 actII-ORF4, ACT cluster activator protein 36 72 GAAGGCGACC 81 
SCO5236 2.86 nagB, putative glucosamine phosphate isomerase 48 -213 GGTCGCGTTC -204 
SCO5330 3.26 Hypothetical protein SC6G9.03c 36 -975 GAAGGGGGCG -966 
SCO5332 2.21 Hypothetical protein 36 1134 CTTCGCCTTC 1143 
SCO5632 2.36 Hypothetical protein SC6A9.3 36 -1261 GAACGGGACG -1252 
SCO5638 2.76 Integral membrane protein 36 X 
SCO5691 2.24 Putative secreted sugar hydrolase 48 -777 GAACGCGGCG -768 
SCO5729 2.33 Conserved hypothetical protein SC3C3.15c 36 Not found 
SCO5912 4.30 Probable secreted protease 48 -54 CTCCCCCTTC -45 
SCO5966 2.24 Putative oxidase 48 -803 GAAGGCGGAC -794 
SCO6273 2.18 cpkC, putative type I polyketide synthase 48 3138 CGCCCCGTTC 3147 
SCO6732 2.29 Putative fatty acid oxidative multifunctional enzyme 36 1140 GAAGGCGGCC 1149 
SCO6820 2.94 Putative oxidoreductase 48 -519 GAACGCGGCC -510 
SCO6941 2.55 cvnC8, hypothetical protein SC1G8.13c 36 -306 GGCCGCCTTC -297 
SCO6951 2.55 Conserved hypothetical protein 36 -411 CGCCGCGTTC -402 
SCO6992 2.78 absR1, regulatory protein 48 -321 GAAGGGGACG -312 
SCO7077 2.24 Putative integral membrane protein 36 -294 GAAGGCGGCG -285 
SCO7545 2.45 Putative ABC-transport protein, ATP-binding component 48 -369 GGCCGCGTTC -360 
a Putative AbrC3-target genes indicated by the ChIP-chip analysis. 
b AbrC3-DNA interaction affinity. 
c Time of the ChIP-chip assay at which the shown enrichment ratio has been found. 
d Consensus Binding site sequence: 5’-GAASGSGRMS-3’; Numbers indicate the 
position of the sequence related to the start codon of the corresponding gene. 
The genes that have also shown differential transcription profile are in bold.  
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TABLE 5. AbrC3 overlapping targets in ChIP-chip and transcriptome analyses 
SCO 
Enrichment 
ratioa 
Predicted function of regulated gene Timeb 
Predicted binding site 
sequencec 
SCO0736 1.50 Putative secreted protein 36 -53 GAAGGCGACC -44 
SCO2113 1.59 bfr, putative bacterioferritin 48 -26 GTTCCCGTTC -17 
SCO3328 1.48 bdtA, hypothetical protein 48 -46 GAAGGGGAAG -37 
SCO4596 2.24 abrC3, TCS response regulator 60 -137 CTTCCCGTTC -128 
SCO4709 1.89 rplP, 50S ribosomal protein L16 36 Not found 
SCO5085 2.23 actII-ORF4, ACT cluster activator protein 36 72 GAAGGCGACC 81 
SCO6809 1.77 Putative integral membrane transport protein 48 -112 GAAGGCGGAC -103 
SCO6992 2.78 absR1, regulatory protein 48 -321 GAAGGGGACG -312 
a AbrC3-DNA interaction affinity by ChIP-chip 
b  Time of the ChIP-chip assay at which the shown enrichment ratio has been found. 
c Consensus Binding site sequence: 5’-GAASGSGRMS-3’; Numbers indicate the 
position of the sequence related to the start codon of the corresponding gene 
The genes in bold are up-regulated. The other genes of the table are down-regulated 
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FIGURE’ LEGENDS 
 
Figure 1: Phenotypic study of the mutants, complementation and overexpression 
A) Production of the antibiotics ACT (72 h), CDA (bioassay against B. subtilis at 48 h), 
and RED (48 h), by the parent strain (M145) and the mutants ∆abrC1/2/3 and ∆abrC3 
and their morphological differentiation (MD) on NA medium.  
B) Complementation of ACT production by integration of plasmid pSETabrC3 in the 
mutant strain ∆abrC3 in liquid medium NB (ACT liquid), and ACT (72 h), RED (48 h) 
and their morphological differentiation (MD) on solid NA medium. 
 
Figure 2: Overexpression of AbrC3 in S. coelicolor and S. lividans.  
ACT production of S. coelicolor M145 (left) and S. lividans 66 (right) transformed with 
low copy number plasmid pHJL401 (control) and its derivative pHJLabrC3 in NB 
medium at 5 days. Error bars correspond to three independent experiments. In the 
bottom part a photograph of the corresponding supernatants. 
 
Figure 3: EMSA of AbrC3 protein with ChIP-chip selected promoters 
EMSA of the AbrC3 protein with different concentration of the protein; A) actII-
ORF4p; B) abrC3p; C) SCO0736p; D) absR1p (SCO6992); E) SCO2113p; F) bdtAp 
(SCO3328); G) SCO4709p; H) SCO6809p. S: specific competition control (adding the 
corresponding unlabelled specific probe); N: non-specific competitor DNA (100-fold 
molar excess of sheared sperm salmon DNA), BSA: protein specific control (4 µM of 
BSA protein).  
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Figure 4: Identification of a putative AbrC3-binding sequence in different genes 
A) Consensus sequence identified with the Regulatory Sequence Analysis Tool 
consensus alignment of putative promoters* (up to - 400 bp upstream sequences plus 
+100 from the translational start point) of genes identified by ChIP-chip and EMSAs. 
B) EMSAs of different fragments of the actII-ORF4 promoter* region with 4 µM 
AbrC3 (top panel, a scheme of the amplified fragment location in the promoter*). C) 
EMSA of AbrC3 protein with actII-ORF4 fragment 4 promoter* with different 
concentration of the protein; S: specific competition control (adding 100-fold molar 
excess of unlabelled specific probe); N: non-specific competitor DNA (adding 100-fold 
excess of sheared sperm salmon DNA), BSA: specific control-2 (adding 4 µM of BSA 
protein). 
 
Figure 5: Location of regulatory protein binding sites in the actII-ORF4 promoter* 
region  
Location of the binding sequences described in the literature for the proteins AtrA, 
DraR, and AfsQ1 in the actII-ORF4 promoter* and the position of the deduced target 
sequence for AbrC3 identified in this work 
 
Figure 6. Scheme of the AbrC3 regulon of S. coelicolor. 
Schematic model of the pleiotropic regulatory role of AbrC3 in primary and secondary 
metabolism, morphological differentiation, and the putative gene network governed by 
AbrC3. → positive control (green); —♦ negative control (red); —— direct control 
(solid line); − − − indirect control (dashed line). (1) data from Wang et al., 2013.  
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